Dawn Midwinter

Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease

David A. Lipson, Courtney Crim, Gerard J. Criner et al. · American Journal of Respiratory and Critical Care Medicine · 2020 · 251 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +16

Lung Deflation and Cardiovascular Structure and Function in Chronic Obstructive Pulmonary Disease. A Randomized Controlled Trial

Ian S. Stone, Neil Barnes, W. R. L. James et al. · American Journal of Respiratory and Critical Care Medicine · 2015 · 126 citations · Full text

Medicine, Clinical Sciences, Pharmacology +14

Effects of lapatinib monotherapy: results of a randomised phase II study in therapy-naive patients with locally advanced squamous cell carcinoma of the head and neck

J.M. del Campo, Ricardo Hitt, P. Sebastian et al. · British Journal of Cancer · 2011 · 113 citations · Full text

Medicine, Oncology, Pharmacology +17

Time‐Dependent Risk of Cardiovascular Events Following an Exacerbation in Patients With Chronic Obstructive Pulmonary Disease: Post Hoc Analysis From the IMPACT Trial

Mark T. Dransfield, Gerard J. Criner, David Halpin et al. · Journal of the American Heart Association · 2022 · 79 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +16

INTREPID: single-<i>versus</i>multiple-inhaler triple therapy for COPD in usual clinical practice

David Halpin, Sally Worsley, Afisi Ismaila et al. · ERJ Open Research · 2021 · 69 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17